��������

The Medical and Clinical Team at AnHeart Therapeutics is responsible for overseeing the clinical development and safety monitoring of the company's pipeline of precision oncology therapeutics. This includes designing and managing clinical trials, ensuring regulatory compliance, analyzing clinical data, and advancing the development of key assets like taletrectinib, AB-218, and AB-329. The team comprises experts in pharmacovigilance, medical strategy, and clinical pharmacology, dedicated to ensuring the safety and efficacy of treatments for patients with high unmet medical needs.